Robin Harper Cowie - 12 Aug 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
CFO, Sec'y & Treasurer
Signature
/s/ Robin Harper Cowie
Issuer symbol
BDSX
Transactions as of
12 Aug 2025
Net transactions value
-$411
Form type
4
Filing time
14 Aug 2025, 17:25:14 UTC
Previous filing
13 May 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cowie Robin Harper CFO, Sec'y & Treasurer 919 WEST DILLON RD, LOUISVILLE /s/ Robin Harper Cowie 14 Aug 2025 0001827690

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +3,157 +1.3% 251,782 12 Aug 2025 Direct F1
transaction BDSX Common Stock Sale $411 -988 -0.39% $0.4163 250,794 13 Aug 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -3,157 -33% $0.000000 6,313 12 Aug 2025 Common Stock 3,157 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F3 The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.